Research Finds Increased Risk In Pancreatic Cancer

Research Finds Increased Risk In Pancreatic Cancer
Jan 25, 2018 Gayle Gerling Pettinga Read Time: < 1 minute

2018:  Researchers compared data from over 33,000 diabetes patients on incretin mimetics with over 525,000 other diabetes patients treated with other medication. They found that patients taking the incretin mimetics had double the risk of developing pancreatic cancer as those taking other medication.

Reference:  Boniol, Mathieu, et al. “Incretin-Based Therapies and the Short-Term Risk of Pancreatic Cancer: Results From Two Retrospective Cohort Studies.” Diabetes Care, American Diabetes Association, 1 Feb. 2018, care.diabetesjournals.org/content/41/2/286.

By: Gayle Gerling Pettinga

Born and raised in Evansville, Gayle is a respected, experienced lawyer and a valued community leader. She graduated near the top of her class at Indiana University’s prestigious Maurer School of Law. She’s practiced law with one of the largest firms in Indianapolis as well as one of the largest pharmaceutical companies in the world. And that means she knows how big law firms and big companies think and how they operate – and she will put that knowledge to work for you.

Gayle has received numerous awards and honors including Martindale-Hubbell — Peer Review Rated: AV®, American Institute of Personal Injury Attorneys 10 Best Attorneys in Indiana for Exceptional and Outstanding Client Service, and YWCA Evansville 100 Years, 100 Women Honoree, 2011.

(888) 437-5464
Jump to a Topic  Schedule Your Free Consultation